EMA committee recommends change to marketing authorization terms for Feraccru Feb. 26, 2018 No Comments
Oxford BioMedica enters collaboration and license agreement with Bioverativ in hemophilia Feb. 15, 2018 No Comments
Lee's licenses development and commercialization rights to GCC-4401C in China and SE Asia Feb. 14, 2018 No Comments
Phase III quality of life data reported for turoctocog alfa pegol in hemophilia A Feb. 12, 2018 No Comments
RSS